PATENT CLAIM ANALYSIS

Application Number: 16353135
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "093400"]

Abstract:
Provided herein is an anti-allergic agent for ameliorating an allergic disease in infants, particularly newborns, without causing side effects. The anti-allergic agent for infants comprises a  bifidobacterium.

Claim (Index 15):
The method according to  claim 14 , wherein the  bifidobacterium  is administered in an amount of 10 8  to 10 12  in terms of the number of bacteria per day continuously for 1 to 12 months.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 99.0
- Lexical Diversity: 1.29167
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13319646', '16353678', '12664785', '14911037', '13583266']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7327361353639908
- 35 USC 102 Novelty (BERT): 0.4836782017018715
- Combined Prediction Score: 0.707830341997779
- Mean Citation Score: 186.852974
- Max Citation Score: 193.56291
- Similarity Product: 144.54282559474825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test